SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: margie who wrote (4496)6/16/1998 1:29:00 PM
From: Steve Fancy  Read Replies (1) of 6136
 
Margie, PaineWebber had indicated that AGPH would release Phase I trial information on AG3340 at some gathering on June 16, so I would guess you are right. Not much anticipation ahead of this news. I'll be disappointed if I have to go looking for the news, rather than it showing up in my mailbox as most significant news does. I suspect the huge selling pressure the last couple of days is mutual fund end of quarter window dressing. In my mind, it's either that, or we're seeing sifnificant institutional bailing for other reasons.

Anyone heard any word from Doug Lind at Morgan Stanley on AGPH's latest news with IMNR?

sf
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext